Open Access
EVALUATING FGF-23 AS A MARKER FOR VULNERABLE CAROTID PLAQUES: A SYSTEMATIC REVIEW OF THE LITERATURE
4
Department of Cardiology, University of California, San Francisco (UCSF), San Francisco, USA
Abstract
Carotid atherosclerosis, a leading cause of ischemic stroke, is characterized by the formation of plaques that can rupture and lead to embolization. Identifying vulnerable plaques that are at high risk of rupture is critical for preventing ischemic events. Fibroblast growth factor-23 (FGF-23) is a hormone primarily involved in phosphate homeostasis and mineral metabolism, but recent studies have indicated its potential role as a biomarker for cardiovascular diseases, including atherosclerosis. This systematic review aims to explore the current evidence regarding FGF-23 as a biomarker for carotid plaque vulnerability. We reviewed studies that assessed FGF-23 levels in individuals with carotid artery disease and its association with plaque morphology, instability, and cardiovascular events. Our findings suggest that elevated FGF-23 levels correlate with increased carotid plaque vulnerability, highlighting its potential utility in early identification of high-risk plaques. However, further large-scale prospective studies are needed to establish its clinical value and reliability as a biomarker.
Keywords
Fibroblast growth factor-23,
carotid artery,
plaque vulnerability
References
Dossabhoy, S.; Arya, S. Epidemiology of atherosclerotic carotid artery disease. Semin. Vasc. Surg. 2021, 34, 3–9. [Google Scholar] [CrossRef] [PubMed]
Bejot, Y.; Bailly, H.; Durier, J.; Giroud, M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Méd. 2016, 45 Pt 2, e391–e398. [Google Scholar] [CrossRef] [PubMed]
Naylor, A.R.; Ricco, J.B.; de Borst, G.J.; Debus, S.; de Haro, J.; Halliday, A.; Hamilton, G.; Kakisis, J.; Kakkos, S.; Lepidi, S.; et al. Editor’s Choice—Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur. J. Vasc. Endovasc. Surg. 2018, 55, 3–81. [Google Scholar] [CrossRef]
Shinohara, Y.; Nagayama, M.; Origasa, H. Postpublication external review of the Japanese guidelines for the management of stroke 2004. Stroke 2009, 40, 1439–1443. [Google Scholar] [CrossRef] [PubMed]
Naylor, R.; Rantner, B.; Ancetti, S.; de Borst, G.J.; De Carlo, M.; Halliday, A.; Kakkos, S.K.; Markus, H.S.; McCabe, D.J.H.; Sillesen, H.; et al. Editor’s Choice—European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur. J. Vasc. Endovasc. Surg. 2023, 65, 7–111. [Google Scholar] [CrossRef]
Verhoeven, B.A.; de Vries, J.P.; Pasterkamp, G.; Ackerstaff, R.G.; Schoneveld, A.H.; Velema, E.; de Kleijn, D.P.; Moll, F.L. Carotid atherosclerotic plaque characteristics are associated with microembolization during carotid endarterectomy and procedural outcome. Stroke 2005, 36, 1735–1740. [Google Scholar] [CrossRef]
Niculescu, R.; Russu, E.; Arbanasi, E.M.; Kaller, R.; Arbanasi, E.M.; Melinte, R.M.; Cosarca, C.M.; Cocuz, I.G.; Sabau, A.H.; Tinca, A.C.; et al. Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. Int. J. Environ. Res. Public Health 2022, 19, 13934. [Google Scholar] [CrossRef]
Miceli, G.; Basso, M.G.; Pintus, C.; Pennacchio, A.R.; Cocciola, E.; Cuffaro, M.; Profita, M.; Rizzo, G.; Tuttolomondo, A. Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review. Int. J. Mol. Sci. 2024, 25, 4351. [Google Scholar] [CrossRef]
Seiler, S.; Reichart, B.; Roth, D.; Seibert, E.; Fliser, D.; Heine, G.H. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol. Dial. Transplant. 2010, 25, 3983–3989. [Google Scholar] [CrossRef]
Kumar, T.; Mohanty, S.; Rani, A.; Malik, A.; Kumar, R.; Bhashker, G. Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification. Indian J. Nephrol. 2022, 32, 560–566. [Google Scholar] [CrossRef]
Yilmaz, G.; Ustundag, S.; Temizoz, O.; Sut, N.; Demir, M.; Ermis, V.; Sevinc, C.; Ustundag, A. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease. Clin. Lab. 2015, 61, 1061–1070. [Google Scholar] [CrossRef] [PubMed]
Chang, Y.; Kim, J.; Woo, H.G.; Ryu, D.R.; Oh, H.J.; Song, T.J. Plasma Fibroblast Growth Factor 23 Concentration Is Associated with Intracranial Cerebral Atherosclerosis in Acute Ischemic Stroke Patients. J. Clin. Neurol. 2020, 16, 29–36. [Google Scholar] [CrossRef] [PubMed]
Lim, K.; Lu, T.S.; Molostvov, G.; Lee, C.; Lam, F.T.; Zehnder, D.; Hsiao, L.L. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012, 125, 2243–2255. [Google Scholar] [CrossRef]
Mencke, R.; Harms, G.; Mirkovic, K.; Struik, J.; Van Ark, J.; Van Loon, E.; Verkaik, M.; De Borst, M.H.; Zeebregts, C.J.; Hoenderop, J.G.; et al. Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue. Cardiovasc. Res. 2015, 108, 220–231. [Google Scholar] [CrossRef]
Kuro, O.M. The FGF23 and Klotho system beyond mineral metabolism. Clin. Exp. Nephrol. 2017, 21, 64–69. [Google Scholar] [CrossRef]
Donate-Correa, J.; Muros de Fuentes, M.; Mora-Fernandez, C.; Navarro-Gonzalez, J.F. Pathophysiological implications of fibroblast growth factor-23 and Klotho and their potential role as clinical biomarkers. Clin. Chem. 2014, 60, 933–940. [Google Scholar] [CrossRef]
Vogt, I.; Haffner, D.; Leifheit-Nestler, M. FGF23 and Phosphate-Cardiovascular Toxins in CKD. Toxins 2019, 11, 647. [Google Scholar] [CrossRef] [PubMed]
Edmonston, D.; Grabner, A.; Wolf, M. FGF23 and klotho at the intersection of kidney and cardiovascular disease. Nat. Rev. Cardiol. 2024, 21, 11–24. [Google Scholar] [CrossRef]
Marthi, A.; Donovan, K.; Haynes, R.; Wheeler, D.C.; Baigent, C.; Rooney, C.M.; Landray, M.J.; Moe, S.M.; Yang, J.; Holland, L.; et al. Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis. J. Am. Soc. Nephrol. 2018, 29, 2015–2027. [Google Scholar] [CrossRef]
Rodriguez-Ortiz, M.E.; Alcala-Diaz, J.F.; Canalejo, A.; Torres-Pena, J.D.; Gomez-Delgado, F.; Munoz-Castaneda, J.R.; Delgado-Lista, J.; Rodriguez, M.; Lopez-Miranda, J.; Almaden, Y. Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study. Eur. J. Intern. Med. 2020, 74, 79–85. [Google Scholar] [CrossRef]
Shah, N.H.; Dong, C.; Elkind, M.S.; Sacco, R.L.; Mendez, A.J.; Hudson, B.I.; Silverberg, S.; Wolf, M.; Rundek, T.; Wright, C.B. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 2048–2053. [Google Scholar] [CrossRef]
Biscetti, F.; Straface, G.; Porreca, C.F.; Bertoletti, G.; Vincenzoni, C.; Snider, F.; Stigliano, E.; Arena, V.; Angelini, F.; Pecorini, G.; et al. Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. Cardiovasc. Diabetol. 2015, 14, 139. [Google Scholar] [CrossRef] [PubMed]
Del Porto, F.; Proietta, M.; di Gioia, C.; Cifani, N.; Dito, R.; Fantozzi, C.; Ferri, L.; Fabriani, L.; Rossi, M.; Tritapepe, L.; et al. FGF-23 levels in patients with critical carotid artery stenosis. Intern. Emerg. Med. 2015, 10, 437–444. [Google Scholar] [CrossRef]
Zamani, M.; Skagen, K.; Lindberg, B.; Bjerkeli, V.; Aukrust, P.; Halvorsen, B.; Skjelland, M. Relationship between fibroblast growth factor in plasma and carotid plaque neovascularization: A pilot study. Front. Immunol. 2024, 15, 1385377. [Google Scholar] [CrossRef] [PubMed]
Bi, J.; Zheng, M.; Li, K.; Sun, S.; Zhang, Z.; Yan, N.; Li, X. Relationships of serum FGF23 and alpha-klotho with atherosclerosis in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 2024, 23, 128. [Google Scholar] [CrossRef]
How to Cite
EVALUATING FGF-23 AS A MARKER FOR VULNERABLE CAROTID PLAQUES: A SYSTEMATIC REVIEW OF THE LITERATURE. (2025). Global Journal of Medical and Pharmaceutical Sciences, 4(04), 1-7. https://doi.org/10.55640/
Most read articles by the same author(s)
- Abdallah Bashir, RELATIONSHIP BETWEEN FINGERPRINT PATTERNS AND BLOOD GROUPS IN LIBYAN STUDENTS: A COMPARATIVE STUDY , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 07 (2024): Volume 03 Issue 07
- Nasir Shaima, PAP SMEAR SCREENING: INSIGHTS INTO KNOWLEDGE, ATTITUDE, AND PRACTICE AMONG WOMEN IN ABU DHABI'S PRIMARY HEALTHCARE CENTERS , Global Journal of Medical and Pharmaceutical Sciences: Vol. 2 No. 05 (2023): Volume 02 Issue 05
- Zeynep Adem, EVALUATING SINUS PATHOLOGIES IN CLEFT LIP AND PALATE PATIENTS: A CBCT ANALYSIS , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 02 (2024): Volume 03 Issue 02
- Raman Singh, EXAMINING PREGNANCY OUTCOMES AFTER EXTERNAL CEPHALIC VERSION FOR BREECH PRESENTATION , Global Journal of Medical and Pharmaceutical Sciences: Vol. 2 No. 11 (2023): Volume 02 Issue 11
- Orimer Alshehri, COMPARATIVE MORPHOLOGICAL ANALYSIS OF PARANASAL SINUSES IN HUMAN AND ANIMAL CADAVERS , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 06 (2024): Volume 03 Issue 06
- Kishore Roy, Md. Rafiqul Yasmen, ANALYZING ANALGESIC PRESCRIPTION PATTERNS AMONG OUTPATIENTS IN THREE SOUTH-WEST CITIES OF BANGLADESH , Global Journal of Medical and Pharmaceutical Sciences: Vol. 2 No. 02 (2023): Volume 02 Issue 02
- Pritesh Bhawsar, UNVEILING THE IMPACT: URANIUM CONTAMINATION'S EFFECTS ON SOIL BACTERIAL COMMUNITIES , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 05 (2024): Volume 03 Issue 05
- Sana Ansari, Zineb Hassan, UNVEILING FOLLICULAR THYROID CARCINOMA: A CASE OF EXTENSIVE CHEST WALL METASTASIS , Global Journal of Medical and Pharmaceutical Sciences: Vol. 2 No. 01 (2023): Volume 02 Issue 01
- Arlinda Bezati, SUBUNGUAL GLOMUS TUMOR: CLINICAL PRESENTATION AND SURGICAL OUTCOMES , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 10 (2024): Volume 03 Issue 10
- Kasim Leafed, IMPACT OF OCCUPATIONAL EXPOSURE ON PERIODONTAL HEALTH AND ANTIOXIDANT LEVELS AMONG DIESEL GENERATOR WORKERS , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 07 (2024): Volume 03 Issue 07
Similar Articles
- Jong-Min Choi, Won-Sik Chung, THE INFLUENCE OF FERMENTED ALOE CORTEX RESIDUE AS FEED ADDITIVES ON PIG GROWTH PERFORMANCE , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 03 (2024): Volume 03 Issue 03
- Dr. Jorvin S. Halstrom, Scalable Vulnerability Management in the Internet of Medical Things: An AI-Driven Automated Framework for Threat Mitigation in High-Asset Environments , Global Journal of Medical and Pharmaceutical Sciences: Vol. 4 No. 11 (2025): Volume 04 Issue 11
- Dr. Kenji Tanaka, Dr. Kenji Tanaka, A Radiographic and Anatomical Review of Ponticulus Anomalies in the Atlas (C1) Vertebra: Prevalence, Morphology, and Clinical Significance , Global Journal of Medical and Pharmaceutical Sciences: Vol. 4 No. 10 (2025): Volume 04 Issue 10
- B. Arun Babu, AUGMENTING WITHAFERIN-A'S ANTIPROLIFERATIVE POTENTIAL AGAINST EXPERIMENTAL HEPATOCELLULAR CARCINOMA , Global Journal of Medical and Pharmaceutical Sciences: Vol. 2 No. 07 (2023): Volume 02 Issue 07
- Dr. Rafael J. Quintana, Comprehensive Contemporary Perspectives On Convulsive And Nonconvulsive Status Epilepticus Across The Lifespan: Definitions, Pathophysiology, Timeliness Of Therapy, And Evidence-Based Management , Global Journal of Medical and Pharmaceutical Sciences: Vol. 5 No. 02 (2026): Volume 05 Issue 02
- Kasim Leafed, IMPACT OF OCCUPATIONAL EXPOSURE ON PERIODONTAL HEALTH AND ANTIOXIDANT LEVELS AMONG DIESEL GENERATOR WORKERS , Global Journal of Medical and Pharmaceutical Sciences: Vol. 3 No. 07 (2024): Volume 03 Issue 07
You may also start an advanced similarity search for this article.